Petal Surgical

The company secured new financing led by Blue Pool Capital, with participation from Salience Capital, A&E Investments, TIME Ventures, and existing investors including Actions Capital.

Petal is developing a new approach to surgery that avoids invasive tissue manipulation.

Petal uses focused sound waves to destroy harmful tissue without cuts, heat, or toxicity, offering a gentler alternative to traditional surgery.

Blue Pool Capital leads a new financing round for **Petal Surgical**, backed by Salience Capital, A&E Investments, TIME Ventures, and existing investor Actions Capital. The company advances its **incisionless surgery platform** toward first-in-human studies, following preclinical progress. The funding supports further development of its minimally invasive surgical technology.

Jun 2026Petal SurgicalNews article

Petal Surgical secures additional funding to advance its incisionless surgery platform ahead of first-in-human trials. The round was led by Blue Pool Capital, with participation from Salience Capital, A&E Investments, TIME Ventures, and existing investors like Actions Capital. The company previously raised a $10 million Series A in late 2023.

Jun 2026The Robot ReportNews article

Petal Surgical is securing further funding to advance its incisionless surgery platform, which uses **Millisecond Pulse Histotripsy** to liquefy tissue via acoustic waves. The company integrates this technology with **AI and robotics** to enable non-invasive surgical procedures, addressing a long-standing limitation in medical interventions. Early traction suggests potential disruption in traditional surgical methods.

Mar 2026Petal SurgicalNews article

Petal Surgical develops acoustic liquefaction technology to enable noninvasive, incisionless surgical procedures. The company’s approach aims to replace traditional cutting methods with sound-based techniques. Co-founder and CEO Prash Chopra leads the innovation in precision medical interventions.

Oct 2025Medical Design and OutsourcingNews article